[The role of expression of histocompatibility antigens class II (HLA-D) and interleukin-2 receptor in the process of rejection of transplanted organs].
Nowaczyk
M
M
Zakładu Immunologii Instytutu Transplantologii AM w Warszawie.
D006084:Graft Rejection / Q000235:genetics / Q000276:immunology*; D006682:HLA-DP Antigens / Q000032:analysis / Q000235:genetics / Q000276:immunology*; D006683:HLA-DQ Antigens / Q000032:analysis / Q000235:genetics / Q000276:immunology*; D006684:HLA-DR Antigens / Q000032:analysis / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007668:Kidney / Q000276:immunology*; D016030:Kidney Transplantation / Q000276:immunology*; D010641:Phenotype; D011379:Prognosis; D015375:Receptors, Interleukin-2 / Q000032:analysis / Q000235:genetics / Q000276:immunology*
D006682:HLA-DP Antigens; D006683:HLA-DQ Antigens; D006684:HLA-DR Antigens; D015375:Receptors, Interleukin-2
Znaczenie ekspresji antygenów zgodności tkankowej klasy drugiej (HLA-D) i receptora dla interleukiny 2 (R-IL2) w procesie odrzucania przeszczepionych narzadów.